MG
THC icon

Michael Gelband’s Tenet Healthcare THC Stock Holding History

Michael Gelband’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.6M Buy
35,291
+8,948
+34% +$1.65M 0.04% 413
2026
Q1 		$4.97M Sell
26,343
-2,421
-8% -$510K 0.04% 442
2025
Q4 		$5.72M Buy
28,764
+10,301
+56% +$2.08M 0.04% 428
2025
Q3 		$3.75M Sell
18,463
-104,380
-85% -$18.5M 0.04% 513
2025
Q2 		$21.6M Sell
122,843
-148,790
-55% -$22.4M 0.19% 103
2025
Q1 		$36.5M Buy
271,633
+254,640
+1,498% +$33.5M 0.36% 38
2024
Q4 		$2.15M Sell
16,993
-66,054
-80% -$9.82M 0.01% 690
2024
Q3 		$13.8M Sell
83,047
-188,531
-69% -$28.5M 0.08% 185
2024
Q2 		$36.1M Sell
271,578
-51,693
-16% -$6.22M 0.25% 62
2024
Q1 		$34M Buy
323,271
+115,368
+55% +$10.4M 0.26% 57
2023
Q4 		$15.7M Buy
207,903
+131,023
+170% +$8.31M 0.1% 137
2023
Q3 		$5.07M Sell
76,880
-121,629
-61% -$9.09M 0.05% 369
2023
Q2 		$16.2M Sell
198,509
-139,935
-41% -$9.96M 0.13% 152
2023
Q1 		$20.1M Buy
338,444
+324,108
+2,261% +$18M 0.17% 107
2022
Q4 		$699K Buy
+14,336
New +$663K 0.01% 1069
2022
Q3 		– Sell
-176,618
Closed -$9.28M – 2307
2022
Q2 		$9.28M Buy
+176,618
New +$12.3M 0.11% 207
2021
Q3 		– Sell
-3,413
Closed -$229K – 2625
2021
Q2 		$229K Sell
3,413
-9,138
-73% -$567K ﹤0.01% 1904
2021
Q1 		$653K Buy
+12,551
New +$635K 0.01% 1176
2020
Q4 		– Sell
-12,356
Closed -$303K – 2374
2020
Q3 		$303K Buy
+12,356
New +$316K 0.01% 1277
2019
Q4 		– Sell
-29,200
Closed -$646K – 1876
2019
Q3 		$646K Sell
29,200
-6,462
-18% -$138K 0.02% 549
2019
Q2 		$737K Buy
+35,662
New +$822K 0.03% 345

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Michael Gelband's THC Position: Q2 2026 in Review

Michael Gelband increased its Tenet Healthcare (THC) stake by 34% in Q2 2026, buying an estimated $1.65M and bringing the position to 35,291 shares worth $6.6M. The position accounts for 0.04% of the portfolio, ranked #413.

Michael Gelband first reported a position in THC in Q2 2019 and has held it in 21 quarters since. The position peaked at $36.5M in Q1 2025. 673 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Michael Gelband held 35,291 shares of Tenet Healthcare worth $6.6M as of Q2 2026.
  • Michael Gelband bought 8,948 Tenet Healthcare shares in Q2 2026, an estimated $1.65M.
  • Tenet Healthcare made up 0.04% of Michael Gelband's portfolio in Q2 2026, its #413 holding.
  • Michael Gelband first reported a position in Tenet Healthcare in Q2 2019 and has held it in 21 quarters since.
  • Michael Gelband's Tenet Healthcare position peaked at $36.5M in Q1 2025.
  • 673 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.